The increased LEPR expression observed in the Obese group suggests that the receptor plays a modulating role in the skin system control and that serum LEP may have a role in the pathogenesis of skin disease associated with obesity [61]. The gene discussed is LEPR; the disease is obesity due to melanocortin 4 receptor deficiency.